Literature DB >> 22286198

Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1.

Fabio Bignami1, Elisabetta Pilotti, Linda Bertoncelli, Paola Ronzi, Mariolina Gulli, Nelson Marmiroli, Giacomo Magnani, Marcello Pinti, Lucia Lopalco, Cristina Mussini, Roberta Ruotolo, Massimo Galli, Andrea Cossarizza, Claudio Casoli.   

Abstract

MicroRNAs (miRNAs) inhibit HIV-1 expression by either modulating host innate immunity or by directly interfering with viral mRNAs. We evaluated the expression of 377 miRNAs in CD4(+) T cells from HIV-1 élite long-term nonprogressors (éLTNPs), naive patients, and multiply exposed uninfected (MEU) patients, and we observed that the éLTNP patients clustered with naive patients, whereas all MEU subjects grouped together. The discriminatory power of miRNAs showed that 21 miRNAs significantly differentiated éLTNP from MEU patients and 23 miRNAs distinguished naive from MEU patients, whereas only 1 miRNA (miR-155) discriminated éLTNP from naive patients. We proposed that miRNA expression may discriminate between HIV-1-infected and -exposed but negative patients. Analysis of miRNAs expression after exposure of healthy CD4(+) T cells to gp120 in vitro confirmed our hypothesis that a miRNA profile could be the result not only of a productive infection but also of the exposure to HIV-1 products that leave a signature in immune cells. The comparison of normalized Dicer and Drosha expression in ex vivo and in vitro condition revealed that these enzymes did not affect the change of miRNA profiles, supporting the existence of a Dicer-independent biogenesis pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286198     DOI: 10.1182/blood-2011-09-379503

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis.

Authors:  Kenneth W Witwer; Janice E Clements
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

Review 2.  Role of miR-155 in the regulation of lymphocyte immune function and disease.

Authors:  Nabila Seddiki; Vedran Brezar; Nicolas Ruffin; Yves Lévy; Sanjay Swaminathan
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 3.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 4.  MicroRNAs and HIV-1: complex interactions.

Authors:  Zachary Klase; Laurent Houzet; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

5.  Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.

Authors:  Dharma R Thapa; Shehnaz K Hussain; Wen-Ching Tran; Gypsyamber Dʼsouza; Jay H Bream; Chad J Achenback; Velpandi Ayyavoo; Roger Detels; Otoniel Martínez-Maza
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

6.  Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection.

Authors:  Jennifer A Fulcher; Georgios Koukos; Marina Koutsioumpa; Julie Elliott; Alexandra Drakaki; Dimitrios Iliopoulos; Peter A Anton
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

7.  Suppression of transforming growth factor β receptor 2 and Smad5 is associated with high levels of microRNA miR-155 in the oral mucosa during chronic simian immunodeficiency virus infection.

Authors:  Jeffy George; Mark G Lewis; Rolf Renne; Joseph J Mattapallil
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

Review 8.  Data submission and quality in microarray-based microRNA profiling.

Authors:  Kenneth W Witwer
Journal:  Clin Chem       Date:  2013-02       Impact factor: 8.327

9.  Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV.

Authors:  Wilfried Wenceslas Bazié; Benjamin Goyer; Julien Boucher; Yuwei Zhang; Delphine Planas; Debashree Chatterjee; Jean-Pierre Routy; Michel Alary; Petronela Ancuta; Caroline Gilbert
Journal:  Pathogens       Date:  2021-04-24

Review 10.  Epigenetic Mechanisms of HIV-1 Persistence.

Authors:  Roxane Verdikt; Olivier Hernalsteens; Carine Van Lint
Journal:  Vaccines (Basel)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.